-
-
-
-
-
-
-
Roche wins FDA clearance for vaginitis PCR diagnostic test
-
-
-
-
-
-
-
Cantor Fitzgerald: 'We now expect apitegromab to have near complete market share'
-
-
-
-
-
-
-
Genentech reports positive Phase III results for uveitic macular edema drug
-
-
-
-
-
-
-
FDA rejects Genentech's Columvi combination for lymphoma treatment
-
-
-
-
-
-
-
FDA Approves Genentech’s Susvimo as Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
-
-
-
-
-
-
-
Roche stock down 5% after disappointing drug trial data update
-
-
-
-
-
-
-
Roche Holding (ROG:SW) (RHHBY) PT Raised to CHF305 at Bernstein SocGen Group
-
480,652 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


